Death-defining immune responses after apoptosis

American Journal of Transplantation

Volumn 14, Issue 7, 2014, Pages 1488-1498

  Campisi, L ^a   Cummings, R J ^a   Blander, J Magarian ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; immunology; infection; innate and adaptive immunity; phagocytosis; tolerance

Indexed keywords

APOPTOSIS; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL DEATH; CELL FATE; CELL MEMBRANE; GENETICS; HOST; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MICROENVIRONMENT; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL; IMMUNOLOGY; INFECTION; INNATE IMMUNITY; ORGAN TRANSPLANTATION; PATHOLOGY;

APOPTOSIS; HUMANS; IMMUNITY, INNATE; INFECTION; INFLAMMATION; ORGAN TRANSPLANTATION;

EID: 84903168901     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12736     Document Type: Review

References (65)

1. Nagata S, Hanayama R, Kawane K., Autoimmunity and the clearance of dead cells. Cell 2010; 140: 619-630.
2. Green DR, Ferguson T, Zitvogel L, Kroemer G., Immunogenic and tolerogenic cell death. Nat Rev Immunolo 2009; 9: 353-363.
3. Takeuchi O, Akira S., Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820.
4. Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-120.
5. Griffith TS, Ferguson TA., Cell death in the maintenance and abrogation of tolerance: The five Ws of dying cells. Immunity 2011; 35: 456-466.
6. Torchinsky MB, Garaude J, Martin AP, Blander JM., Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 2009; 458: 78-82.
7. Zitvogel L, Kroemer G., Introduction: The immune response against dying cells. Curr Opin Immunol 2008; 20: 501-503.
8. Kerr JF, Wyllie AH, Currie AR., Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
9. Schweichel JU, Merker HJ., The morphology of various types of cell death in prenatal tissues. Teratology 1973; 7: 253-266.
10. Hochreiter-Hufford A, Ravichandran KS., Clearing the dead: Apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol 2013; 5: a008748.
11. Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT., PAMPs and DAMPs: Signal 0s that spur autophagy and immunity. Immunol Rev 2012; 249: 158-175.
12. Torchinsky MB, Garaude J, Blander JM., Infection and apoptosis as a combined inflammatory trigger. Curr Opin Immunol 2010; 22: 55-62.
13. Kurokawa M, Kornbluth S., Caspases and kinases in a death grip. Cell 2009; 138: 838-854.
14. Kaczmarek A, Vandenabeele P, Krysko DV., Necroptosis: The release of damage-associated molecular patterns and its physiological relevance. Immunity 2013; 38: 209-223.
15. Brint E, O'Callaghan G, Houston A., Life in the Fas lane: Differential outcomes of Fas signaling. Cell Mol Life Sci 2013; 70: 4085-4099.
16. Ozturk S, Schleich K, Lavrik IN., Cellular FLICE-like inhibitory proteins (c-FLIPs): Fine-tuners of life and death decisions. Exp Cell Res 2012; 318: 1324-1331.
17. Fricker N, Beaudouin J, Richter P, Eils R, Krammer PH, Lavrik IN., Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL. J Cell Biol 2010; 190: 377-389.
18. Martinou JC, Youle RJ., Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 2011; 21: 92-101.
19. Wang C, Youle RJ., The role of mitochondria in apoptosis*. Annu Rev Genet 2009; 43: 95-118.
20. Beug ST, Cheung HH, LaCasse EC, Korneluk RG., Modulation of immune signalling by inhibitors of apoptosis. Trends Immunol 2012; 33: 535-545.
21. Dubrez L, Berthelet J, Glorian V., IAP proteins as targets for drug development in oncology. Onco Targets Ther 2013; 9: 1285-1304.
22. Pizarro-Cerda J, Cossart P., Bacterial adhesion and entry into host cells. Cell 2006; 124: 715-727.
23. Mercer J, Schelhaas M, Helenius A., Virus entry by endocytosis. Ann Rev Biochem 2010; 79: 803-833.
24. Kaper JB, Nataro JP, Mobley HL., Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2: 123-140.
25. Nagai T, Abe A, Sasakawa C., Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: Critical role of the 16th leucine residue in EspF. J Biol Chem 2005; 280: 2998-3011.
26. Vallance BA, Deng W, Jacobson K, Finlay BB., Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 2003; 71: 3443-3453.
27. Nougayrede JP, Donnenberg MS., Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell Microbiol 2004; 6: 1097-1111.
28. Ohyagi H, Onai N, Sato T, et al. Monocyte-derived dendritic cells perform hemophagocytosis to fine-tune excessive immune responses. Immunity 2013; 39: 584-598.
29. Flannagan RS, Jaumouille V, Grinstein S., The cell biology of phagocytosis. Ann Rev Pathol 2012; 7: 61-98.
30. Blander JM, Medzhitov R., Regulation of phagosome maturation by signals from toll-like receptors. Science 2004; 304: 1014-1018.
31. Blander JM, Medzhitov R., Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006; 440: 808-812.
32. Blander JM, Torchinsky MB, Campisi L., Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells. Immunol Res 2012; 54: 50-68.
33. Hober D, Sauter P., Pathogenesis of type 1 diabetes mellitus: Interplay between enterovirus and host. Nat Rev Endocrinol 2010; 6: 279-289.
34. Herold KC, Vignali DA, Cooke A, Bluestone JA., Type 1 diabetes: Translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol 2013; 13: 243-256.
35. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N., Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J Clin Invest 2002; 109: 79-87.
36. Zehn D, Bevan MJ., T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity 2006; 25: 261-270.
37. Uderhardt S, Herrmann M, Oskolkova OV, et al. 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity 2012; 36: 834-846.
38. Steinman RM, Hawiger D, Nussenzweig MC., Tolerogenic dendritic cells. Ann Rev Immunol 2003; 21: 685-711.
39. Bilate AM, Lafaille JJ., Induced CD4+ Foxp3+ regulatory T cells in immune tolerance. Ann Rev Immunol 2012; 30: 733-758.
40. Burzyn D, Benoist C, Mathis D., Regulatory T cells in nonlymphoid tissues. Nat Immunol 2013; 14: 1007-1013.
41. Bailey-Bucktrout SL, Bluestone JA., Regulatory T cells: Stability revisited. Trends Immunol 2011; 32: 301-306.
42. Josefowicz SZ, Lu LF, Rudensky AY., Regulatory T cells: Mechanisms of differentiation and function. Ann Rev Immunol 2012; 30: 531-564.
43. Fadok VA, McDonald PP, Bratton DL, Henson PM., Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem Soc Transac 1998; 26: 653-656.
44. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W., A critical function for TGF-beta signaling in the development of natural CD4+ CD25+ Foxp3+ regulatory T cells. Nat Immunol 2008; 9: 632-640.
45. Perruche S, Zhang P, Liu Y, Saas P, Bluestone JA, Chen W., CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med 2008; 14: 528-535.
46. Morelli AE, Larregina AT., Apoptotic cell-based therapies against transplant rejection: Role of recipient's dendritic cells. Apoptosis 2010; 15: 1083-1097.
47. Saas P, Gaugler B, Perruche S., Intravenous apoptotic cell infusion as a cell-based therapy toward improving hematopoietic cell transplantation outcome. Ann N Y Acad Sci 2010; 1209: 118-126.
48. Saas P, Kaminski S, Perruche S., Prospects of apoptotic cell-based therapies for transplantation and inflammatory diseases. Immunotherapy 2013; 5: 1055-1073.
49. Bittencourt MC, Perruche S, Contassot E, et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001; 98: 224-230.
50. Perruche S, Kleinclauss F, Bittencourt Mde C, Paris D, Tiberghien P, Saas P., Intravenous infusion of apoptotic cells simultaneously with allogeneic hematopoietic grafts alters anti-donor humoral immune responses. Am J Transplant 2004; 4: 1361-1365.
51. Kleinclauss F, Perruche S, Masson E, et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2006; 13: 41-52.
52. Wang Z, Larregina AT, Shufesky WJ, et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 2006; 6: 1297-1311.
53. Ochando JC, Homma C, Yang Y, et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006; 7: 652-662.
54. Alpdogan O, van den Brink MR., Immune tolerance and transplantation. Semin Oncol 2012; 39: 629-642.
55. Bastien JP, Roy J, Roy DC., Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation. Semin Oncol 2012; 39: 674-682.
56. Li XC, Li Y, Dodge I, et al. Induction of allograft tolerance in the absence of Fas-mediated apoptosis. J Immunol 1999; 163: 2500-2507.
57. Wells AD, Li XC, Li Y, et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 1999; 5: 1303-1307.
58. Mizrahi K, Yaniv I, Ash S, Stein J, Askenasy N., Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts. Bone Marrow Transplant 2014; 49: 640-648.
59. Bohana-Kashtan O, Morisot S, Hildreth R, Brayton C, Levitsky HI, Civin CI., Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand. J Immunol 2009; 183: 696-705.
60. Morecki S, Gelfand Y, Yacovlev E, et al. Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses. Bone Marrow Transplant 2012; 47: 838-845.
61. Yarkoni S, Prigozhina TB, Slavin S, Askenasy N., IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: Ex vivo selective depletion of host-reactive T cells and in vivo therapy. Biol Blood Marrow Transplant 2012; 18: 523-535.
62. Crane JK, McNamara BP, Donnenberg MS., Role of EspF in host cell death induced by enteropathogenic Escherichia coli. Cell Microbiol 2001; 3: 197-211.
63. Cusumano G, Mangano V, Chincarini G, et al. Gamma-ray bursts: Huge explosion in the early Universe. Nature 2006; 440: 164.
64. Zheng Y, Valdez PA, Danilenko DM, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14: 282-289.
65. Rosenblum MD, Gratz IK, Paw JS, Lee K, Marshak-Rothstein A, Abbas AK., Response to self antigen imprints regulatory memory in tissues. Nature 2011; 480: 538-542.